BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20

The present invention relates to bispecific antibodies (bsAbs) and the use of such antibodies in the treatment of disease in subjects. Moreover, advantageous treatment regimens are provided for the treatment of B-cell Non-Hodgkin Lymphoma (B-NHL). La presente invención se refiere a anticuerpos biesp...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	GUPTA Manish, CHIU Christopher, AZARYAN Ada, OLIVERI Roberto, R LI Tommy, ELLIOTT Brian, AHMADI Tahamtan, DEMARCO Dena, HIEMSTRA Ida
Format:	Patent
Sprache:	eng ; spa
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to bispecific antibodies (bsAbs) and the use of such antibodies in the treatment of disease in subjects. Moreover, advantageous treatment regimens are provided for the treatment of B-cell Non-Hodgkin Lymphoma (B-NHL). La presente invención se refiere a anticuerpos biespecíficos (bsAbs) y al uso de tales anticuerpos en el tratamiento de enfermedades en sujetos. Además, se proporcionan regímenes de tratamiento ventajosos para el tratamiento del linfoma no Hodgkin de células B (B-NHL).